Company registration number: 7126039
Unaudited financial statements
for the year ended 31 January 2024
for
Pharmabase Marketing Ltd
Pages for filing with the Registrar
Company registration number: 7126039
Pharmabase Marketing Ltd
Balance sheet
as at 31 January 2024
31 Jan 24 31 Jan 23
£ £ £ £
Fixed assets 1,169 785
Current assets 14,592 46,680
Creditors: amounts falling due within one year (28,099) (31,550)
Net current (liabilities)/assets (13,507) 15,130
Total assets less current liabilities (12,338) 15,915
Creditors: amounts falling due after more than
one year
(4,108) (5,333)
NET (LIABILITIES)/ASSETS (16,446) 10,582
CAPITAL AND RESERVES (16,446) 10,582
Notes
1 Company information
Pharmabase Marketing Ltd is a private company registered in England and Wales. Its registered number is 7126039. The company is limited by shares. Its registered office is Aston House, 24 Hayes Barton, Woking, Surrey, GU22 8NH.
2 Average number of employees
During the year the average number of employees was 2 (2023 - 2).
3 Advances, credit and guarantees granted to directors
Nil
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 January 2024.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 7126039
Pharmabase Marketing Ltd
Balance sheet - continued
as at 31 January 2024
The financial statements have been prepared in accordance with the micro-entity provisions.
These financial statements were approved by the Board of directors and authorised for issue on 30 October 2024 and signed on its behalf by:
Mr C Duke, Director
30 October 2024
2
Pharmabase Marketing Ltd
Exception report
for the year ended 31 January 2024
The following differences exist between the previous year's closing balances per the accounts and the
current year's opening balances per the Trial Balance:
Reserves
Opening balance at
1 February 2023 per
TB
Balance at 31
January 2023 per
accounts
Difference
£ £ £
Profit and loss account (Account 968) 10,481 10,482 (1)
10,481 10,482 (1)
This page does not form part of the statutory financial statements.
3